Glaxo, Human Genome Sciences Initiate Phase III Trial Of Belimumab

Date : 12/15/2011 @ 7:43AM
Source : Dow Jones News
Stock : Human Genome Sciences, Inc. (MM) (HGSI)
Quote : 14.24  0.0 (0.00%) @ 2:05AM

Glaxo, Human Genome Sciences Initiate Phase III Trial Of Belimumab

GlaxoSmithKline (LSE:GSK)
Historical Stock Chart

5 Years : From Jul 2012 to Jul 2017

Click Here for more GlaxoSmithKline Charts.

GlaxoSmithKline PLC (GSK.LN) and Human Genome Sciences (HGSI) Thursday announced that dosing has been initiated in BLISS-SC, a new Phase III trial to evaluate the efficacy, safety and tolerability of BENLYSTA administered subcutaneously once-weekly to autoantibody-positive adults with active systemic lupus erythematosus, or SLE.

MAIN FACTS:

-Study to enrol over 800 adult patients with SLE

-Will evaluate once-weekly subcutaneous injections of an investigational formulation of belimumab plus standard of care vs. placebo plus standard of care

-GlaxoSmithKline shares at 1210 GMT up 1.32% at GBP14.6 valuing the company at GBP73.5 billion.

-By Jana Weigand, Dow Jones Newswires; 44-20-7842-9314; jana.weigand@dowjones.com

Latest HGSI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.